Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation.
Liao J, Peng B, Huang G, Diao C, Qin Y, Hong Y, Lin J, Lin Y, Jiang L, Tang N, Tang F, Liang J, Zhang J, Yan Y, Chen Q, Zhou Z, Shen C, Huang W, Huang K, Lan Q, Cui L, Zhong H, Xu F, Li M, Wei Y, Lu P, Zhang M.
Liao J, et al. Among authors: huang k, huang g, huang w.
Biomed Pharmacother. 2023 Sep;165:115052. doi: 10.1016/j.biopha.2023.115052. Epub 2023 Jul 1.
Biomed Pharmacother. 2023.
PMID: 37399715
Free article.